dilazep has been researched along with Injury, Myocardial Reperfusion in 5 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocardial infarction was induced in rabbits by 30-min coronary occlusion and 72-h reperfusion." | 1.29 | Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning. ( Iimura, O; Itoya, M; Miura, T; Sakamoto, J; Urabe, K, 1994) |
| "Dilazep was given 5 min before starting ischemia until the end of ischemia." | 1.29 | A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart. ( Abiko, Y; Hashizume, H; Hoque, AN; Hoque, N, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoya, M | 1 |
| Miura, T | 1 |
| Sakamoto, J | 1 |
| Urabe, K | 1 |
| Iimura, O | 1 |
| Hoque, AN | 3 |
| Hoque, N | 2 |
| Hashizume, H | 4 |
| Abiko, Y | 4 |
| Hara, A | 2 |
| Magishi, K | 1 |
1 review available for dilazep and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
[A new approach to the understanding of the mechanism of ischemia/reperfusion damage in the heart and the effects of anti-ischemic drugs].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Circulation; Dilazep; Diltiazem; Ene | 1996 |
4 other studies available for dilazep and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.
Topics: Animals; Blood Pressure; Dilazep; Disease Models, Animal; Epoprostenol; Heart Rate; Injections, Intr | 1994 |
A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart.
Topics: Animals; Arachidonic Acid; Coronary Circulation; Coronary Vessels; Dilazep; Fatty Acids, Nonesterifi | 1995 |
A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
Topics: Animals; Blood Pressure; Dilazep; Fatty Acids, Nonesterified; Heart; Heart Rate; In Vitro Techniques | 1995 |
A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Cats; Dilazep; Enzyme Activation; Heart; Humans; In V | 1997 |